Literature DB >> 9051259

5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells.

W Yan1, C C Wilson, J H Haring.   

Abstract

We have previously reported that neonatal (P3) serotonin (5-HT) depletion results in a significant decrease in the number of dendritic spines per 50 microns of dendritic length on dentate granule cells. This effect is specific and permanent. Neither total dendritic length nor the number of dendritic segments is affected by 5-HT depletion. The area dentata contains a dense 5-HT1a receptor population that is present in the at birth. Therefore, 5-HT1a receptors represented a likely candidate for the mediation of the effects of 5-HT on developing granule cells. The present study used the drugs buspirone and NAN-190, which have been shown to be an agonist and antagonist respectively at postsynaptic 5-HT1a receptors in vivo, to test the idea that neurotrophic actions of 5-HT result from 5-HT1a receptor stimulation. Following 5-HT depletion with PCA, pups received daily injections of buspirone (1.0 mg/kg) from P5 to P14. Granule cell morphology was then studied using intracellular filling with Neurobiotin on P14, P21 and P60. Buspirone treatment prevented the loss of dendritic spines previously shown to follow 5-HT depletion with PCA. No other morphological parameters were significantly changed by buspirone treatment. Naive pups received daily injections of NAN-190 from P3 to P14. One group received 1.0 mg/kg while a second group received 3.5 mg/kg. Both doses of NAN-190 resulted in dendritic spine loss comparable to that obtained with neonatal PCA treatment. This loss was permanent suggesting that the first two postnatal weeks may represent a critical period for the action of 5-HT on developing granule cells. Significant, dose-dependent changes in total dendritic length and number of dendritic segments reminiscent of the effects of norepinephrine depletion were also observed in NAN-190-treated rats. We suspect that this change is the result of the action NAN-190 at alpha receptors and is therefore distinct from the specific effect of 5-HT on the number of dendritic spines. The NAN-190 experiment also shows that the loss of dendritic spines is a function of decreased stimulation of 5-HT1a receptors and not the loss of 5-HT terminal membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051259     DOI: 10.1016/s0165-3806(96)00175-7

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  20 in total

1.  WAY-100635, an antagonist of 5-HT(1A) receptor, causes malformations of the CNS in ascidian embryos.

Authors:  Roberta Pennati; Silvia Groppelli; Cristina Sotgia; Giuliana Zega; Mario Pestarino; Fiorenza De Bernardi
Journal:  Dev Genes Evol       Date:  2003-03-25       Impact factor: 0.900

2.  Chronic fluoxetine treatment changes S100B expression during postnatal rat brain development.

Authors:  Nathalie Bock; Emre Koc; Hannah Alter; Veit Roessner; Andreas Becker; Aribert Rothenberger; Till Manzke
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

3.  5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology.

Authors:  Elena Kvachnina; Guoquan Liu; Alexander Dityatev; Ute Renner; Aline Dumuis; Diethelm W Richter; Galina Dityateva; Melitta Schachner; Tatyana A Voyno-Yasenetskaya; Evgeni G Ponimaskin
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 4.  Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases.

Authors:  Evgeni Ponimaskin; Tatyana Voyno-Yasenetskaya; Diethelm W Richter; Melitta Schachner; Alexander Dityatev
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

5.  Brain mapping of language and auditory perception in high-functioning autistic adults: a PET study.

Authors:  R A Müller; M E Behen; R D Rothermel; D C Chugani; O Muzik; T J Mangner; H T Chugani
Journal:  J Autism Dev Disord       Date:  1999-02

Review 6.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

7.  Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.

Authors:  Vincent Martin; Lionel Mathieu; Jorge Diaz; Haysam Salman; Jeanine Alterio; Caroline Chevarin; Laurence Lanfumey; Michel Hamon; Mark C Austin; Michèle Darmon; Craig A Stockmeier; Justine Masson
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

8.  Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain.

Authors:  Paul A T Kelly; Isobel M Ritchie; Linda Quate; Douglas E McBean; Henry J Olverman
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

9.  3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.

Authors:  Michael T Williams; Tori L Schaefer; Lisa A Ehrman; Jessica A Able; Gary A Gudelsky; Renu Sah; Charles V Vorhees
Journal:  Brain Res       Date:  2005-03-28       Impact factor: 3.252

10.  Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors.

Authors:  Sarah J Bailey; Miklos Toth
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.